novo nordisk glp-1 weight loss glp 1 drugs Novo Nordisk's weight-loss pill wins FDA approval-revival-foundation.org Novo Nordisk launches its Wegovy

Linhda Nguyen, PA-C, a physician assistant at the Healthy Weight and Wellness Clinic at Nemours Childrens Health in Wilmington, Delaware, said GLP-1 prescriptions for adolescents have increased since the approval of

New preclinical study provides novel insights into how GIP and GLP-1 work together in the brain to drive weight loss

Pausing tirzepatide is sometimes medically necessary, but interrupting therapy carries real risks of rapid weight regain and metabolic changes

The results of the IPTW and subgroup analyses confirmed those of the main analysis

This approval aligns with the FDAs commitment to advancing patient access to safe, effective, and high-quality generic medications, especially amid current shortages